4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000899243-22-002650
Options or other derivatives
- Chief Financial Officer acquired 115,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Silver Brian M. Chief Financial Officer | 2022-01-18 | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…